Categories

Categories

Top sellers

Catalog

New products

Tablets. The active substance is bisoprolol (bisoprolol). Selective beta1-blocker without its own sympathomimetic activity, does not have a membrane stabilizing effect.

Tablets. The active substance is bisoprolol (bisoprolol). Selective beta1-blocker without its own sympathomimetic activity, does not have a membrane stabilizing effect.

Tablets. The active substance is bisoprolol (bisoprolol). Selective beta1-blocker without its own sympathomimetic activity, does not have a membrane stabilizing effect.

Tablets. The active substance is bisoprolol (bisoprolol). Selective beta1-blocker without its own sympathomimetic activity, does not have a membrane stabilizing effect.

Tablets. Active substances - lisinopril (lisinopril), hydrochlorothiazide (hydrochlorothiazide). Combined antihypertensive drug that contains an angiotensin-converting enzyme inhibitor lisinopril and a thiazide diuretic hydrochlorothiazide. It has antihypertensive and diuretic effects. The hypotensive effect of both components is additive.

Tablets. Active substances - lisinopril (lisinopril), hydrochlorothiazide (hydrochlorothiazide). Combined antihypertensive drug that contains an angiotensin-converting enzyme inhibitor lisinopril and a thiazide diuretic hydrochlorothiazide. It has antihypertensive and diuretic effects. The hypotensive effect of both components is additive.

Tablets. Active substances - lisinopril (lisinopril), hydrochlorothiazide (hydrochlorothiazide). Combined antihypertensive drug that contains an angiotensin-converting enzyme inhibitor lisinopril and a thiazide diuretic hydrochlorothiazide. It has antihypertensive and diuretic effects. The hypotensive effect of both components is additive.

Tablets. The active substance is cilazapril (cilazapril). Long-acting angiotensin-converting enzyme inhibitors. Suppresses the renin-angiotensin-aldosterone system and, thus, the conversion of inactive angiotensin I into angiotensin II, which has a strong vasoconstrictive effect. In recommended doses, the effect of Inhibais in patients with arterial hypertension and in patients with chronic heart failure persists for 24 hours.

Tablets. The active substance is cilazapril (cilazapril). Long-acting angiotensin-converting enzyme inhibitors. Suppresses the renin-angiotensin-aldosterone system and, thus, the conversion of inactive angiotensin I into angiotensin II, which has a strong vasoconstrictive effect. In recommended doses, the effect of Inhibais in patients with arterial hypertension and in patients with chronic heart failure persists for 24 hours.

Tablets. The active substance is cilazapril (cilazapril). Long-acting angiotensin-converting enzyme inhibitors. Suppresses the renin-angiotensin-aldosterone system and, thus, the conversion of inactive angiotensin I into angiotensin II, which has a strong vasoconstrictive effect. In recommended doses, the effect of Inhibais in patients with arterial hypertension and in patients with chronic heart failure persists for 24 hours.

Capsules. The active substance is nifuroxazide (nifuroxazide). Nifuroxazide is an antimicrobial agent, a derivative of nitrofuran. It blocks the activity of dehydrogenases and inhibits the respiratory chains, the tricarboxylic acid cycle and a number of other biochemical processes in the microbial cell. Destroys the membrane of microbial cells, reduces the production of toxins by microorganisms.

Film-coated tablets. The active substance is ursodeoxycholic acid. Hepatoprotector with choleretic and cholelitholytic action. It has a choleretic, cholelitholytic, hypolipidemic, hypocholesterolemic and immunomodulatory effect.

Tablets. The active substance is distigmine bromide. Acetylcholinesterase and pseudocholinesterase inhibitor. It has an indirect cholinomimetic effect due to reversible inhibition of cholinesterase and potentiation of the action of endogenous acetylcholine.

Tablets. The active substance is distigmine bromide. Acetylcholinesterase and pseudocholinesterase inhibitor. It has an indirect cholinomimetic effect due to reversible inhibition of cholinesterase and potentiation of the action of endogenous acetylcholine.

Capsules. The active substance is imatinib (imatinib). Anticancer drug. Protein kinase inhibitor. Inhibits the enzyme Bcr-Abl-tyrosine kinase at the cellular level, in vitro and in vivo. Selectively inhibits proliferation and induces apoptosis of Bcr-Abl positive cell lines, as well as young leukemic cells in Philadelphia chromosome-positive chronic myeloid leukemia and in acute lymphoblastic leukemia.

Capsules. The active substance is imatinib (imatinib). Anticancer drug. Protein kinase inhibitor. Inhibits the enzyme Bcr-Abl-tyrosine kinase at the cellular level, in vitro and in vivo. Selectively inhibits proliferation and induces apoptosis of Bcr-Abl positive cell lines, as well as young leukemic cells in Philadelphia chromosome-positive chronic myeloid leukemia and in acute lymphoblastic leukemia.

Capsules. The active substance is hydroxycarbamide (Hydroxyurea). Hydroxyurea is a phase-specific cytostatic drug (an antimetabolite, according to some sources, an alkylating action), acting in the S phase of the cell cycle.

Capsules. The active substance is hydroxyurea (hydroxycarbamide). Antitumor agent. The proposed mechanism of action is to inhibit the synthesis of deoxyribonucleic acid. Does not affect the synthesis of protein and ribonucleic acid.

Tablets. The active substances are simvastatin and ezetimibe. Combined lipid-lowering agent that reduces the absorption of cholesterol and related plant sterols in the intestine, and also suppresses endogenous cholesterol synthesis.

Tablets. The active substances are simvastatin and ezetimibe. Combined lipid-lowering agent that reduces the absorption of cholesterol and related plant sterols in the intestine, and also suppresses endogenous cholesterol synthesis.

Tablets. The active substances are simvastatin and ezetimibe. Combined lipid-lowering agent that reduces the absorption of cholesterol and related plant sterols in the intestine, and also suppresses endogenous cholesterol synthesis.

Tablets. The active substances are simvastatin and ezetimibe. Combined lipid-lowering agent that reduces the absorption of cholesterol and related plant sterols in the intestine, and also suppresses endogenous cholesterol synthesis.

Tablets. The active ingredient is carvedilol. Carvedilol is a blocker of α1-, β1, - and β2-adrenergic receptors, has an organoprotective effect, is a powerful antioxidant that removes free oxygen radicals, has an antiproliferative effect on smooth muscle cells of the vascular walls.

Tablets. The active ingredient is carvedilol. Carvedilol is a blocker of α1-, β1, - and β2-adrenergic receptors, has an organoprotective effect, is a powerful antioxidant that removes free oxygen radicals, has an antiproliferative effect on smooth muscle cells of the vascular walls.

Capsules. The active substance is trandolapril. Angiotensin-converting enzyme inhibitors. It is a prodrug, which in the body, after hydrolysis, turns into an active substance (trandolaprilat), which disrupts the formation of angiotensin II.

Capsules. The active substance is trandolapril. Angiotensin-converting enzyme inhibitors. It is a prodrug, which in the body, after hydrolysis, turns into an active substance (trandolaprilat), which disrupts the formation of angiotensin II.

Tablets. The active ingredient is ramipril. Ramipril belongs to prodrugs, after absorption it is metabolized in the liver to form ramiprilat. Ramiprilat is a potent long acting angiotensin converting enzyme inhibitor. The angiotensin converting enzyme catalyzes the conversion of angiotensin I to the vasoconstrictor, angiotensin II. 

Tablets. The active ingredient is ramipril. Ramipril belongs to prodrugs, after absorption it is metabolized in the liver to form ramiprilat. Ramiprilat is a potent long acting angiotensin converting enzyme inhibitor. The angiotensin converting enzyme catalyzes the conversion of angiotensin I to the vasoconstrictor, angiotensin II. 

Tablets. The active ingredient is ramipril. Ramipril belongs to prodrugs, after absorption it is metabolized in the liver to form ramiprilat. Ramiprilat is a potent long acting angiotensin converting enzyme inhibitor. The angiotensin converting enzyme catalyzes the conversion of angiotensin I to the vasoconstrictor, angiotensin II. 

Tablets. The active ingredient is ramipril. Ramipril belongs to prodrugs, after absorption it is metabolized in the liver to form ramiprilat. Ramiprilat is a potent long acting angiotensin converting enzyme inhibitor. The angiotensin converting enzyme catalyzes the conversion of angiotensin I to the vasoconstrictor, angiotensin II. 

Tablets. The active ingredient is ramipril. Ramipril belongs to prodrugs, after absorption it is metabolized in the liver to form ramiprilat. Ramiprilat is a potent long acting angiotensin converting enzyme inhibitor. The angiotensin converting enzyme catalyzes the conversion of angiotensin I to the vasoconstrictor, angiotensin II. 

Tablets. The active ingredient is ramipril. Ramipril belongs to prodrugs, after absorption it is metabolized in the liver to form ramiprilat. Ramiprilat is a potent long acting angiotensin converting enzyme inhibitor. The angiotensin converting enzyme catalyzes the conversion of angiotensin I to the vasoconstrictor, angiotensin II. 

Tablets. The active ingredient is ramipril. Ramipril belongs to prodrugs, after absorption it is metabolized in the liver to form ramiprilat. Ramiprilat is a potent long acting angiotensin converting enzyme inhibitor. The angiotensin converting enzyme catalyzes the conversion of angiotensin I to the vasoconstrictor, angiotensin II. 

Aerosol for external use / Cream for external use / Shampoo. The active substance is pyrithione zinc. Dermatoprotective agent. A drug with antiproliferative, antibacterial and antifungal effects for external use.

Aerosol for external use / Cream for external use / Shampoo. The active substance is pyrithione zinc. Dermatoprotective agent. A drug with antiproliferative, antibacterial and antifungal effects for external use.

Aerosol for external use / Cream for external use / Shampoo. The active substance is pyrithione zinc. Dermatoprotective agent. A drug with antiproliferative, antibacterial and antifungal effects for external use.

Capsules. The active ingredient is fluconazole. Fluconazole, a triazole antifungal agent, is a potent selective inhibitor of sterol synthesis in the fungal cell.

Capsules. The active ingredient is fluconazole. Fluconazole, a triazole antifungal agent, is a potent selective inhibitor of sterol synthesis in the fungal cell.

Capsules. The active ingredient is fluconazole. Fluconazole, a triazole antifungal agent, is a potent selective inhibitor of sterol synthesis in the fungal cell.

Capsules. The active ingredient is fluconazole. Fluconazole, a triazole antifungal agent, is a potent selective inhibitor of sterol synthesis in the fungal cell.

Tablets. The main active ingredient of the drug is riluzole. Also included are: anhydrous calcium hydrogen phosphate, granular microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silicon dioxide, magnesium stearate.

A rod-shaped implant for intravitreal administration. The active substance is dexamethasone. Glucocorticosteroid for intravitreal use.

Solution for intraocular administration. The active substance is ranibizumab. An agent for the treatment of exudative-hemorrhagic forms of age-related macular degeneration. Ranibizumab is a human monoclonal antibody fragment against endothelial growth factor A (VEGF-A) and is expressed by a recombinant Escherichia coli strain.

Tablets. The active ingredient is trimebutine (trimebutin). A drug for the treatment of functional disorders of the gastrointestinal tract.

Tablets. The active ingredient is trimebutine (trimebutin). A drug for the treatment of functional disorders of the gastrointestinal tract.

Tablets. The active ingredient is trimebutine (trimebutin). A drug for the treatment of functional disorders of the gastrointestinal tract.

Tablets. The active ingredient is trimebutine (trimebutin). A drug for the treatment of functional disorders of the gastrointestinal tract.

Extended-release tablets. An anti-inflammatory drug used to treat Crohn's disease and ulcerative colitis. It has a local anti-inflammatory effect due to inhibition of the activity of neutrophilic lipoxygenase and the synthesis of prostaglandins and leukotrienes. Slows down migration, degranulation, phagocytosis of neutrophils, as well as the secretion of immunoglobulins by lymphocytes.

Extended-release tablets. An anti-inflammatory drug used to treat Crohn's disease and ulcerative colitis. It has a local anti-inflammatory effect due to inhibition of the activity of neutrophilic lipoxygenase and the synthesis of prostaglandins and leukotrienes. Slows down migration, degranulation, phagocytosis of neutrophils, as well as the secretion of immunoglobulins by lymphocytes.

Suppositories for rectal administration. The active substance is mesalazine. The drug reduces the formation of leukotrienes and cytokinins, neutralizes free radicals, inhibits chemotaxis of leukocytes.